F236. CLONIDINE NORMALIZES MMN IN SCHIZOPHRENIA PATIENTS ON STABLE MEDICATION

BACKGROUND: Schizophrenia is a severe brain disorder with profound deficits in prefrontal cortical cognitive functioning. These cognitive deficits form a core feature in schizophrenia for which treatment has been proven to be clinically challenging. One of the key neurotransmitters involved in cogni...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruiper, Caitlyn, Glenthoj, Birte, Oranje, Bob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887673/
http://dx.doi.org/10.1093/schbul/sby017.767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887673/
http://dx.doi.org/10.1093/schbul/sby017.767

Ejemplares similares